Print this page    •   Back to Web version of article

International News
Boehringer Ingelheim Launches Hepatitis C Website

November 13, 2012

On November 9, pharmaceutical company Boehringer Ingelheim announced the launch of a website -- HepCRedefined.com -- that is designed for patients with hepatitis C and their advocates. The company describes the website as an online portal designed to improve the lives of those living with the virus through education, information, and understanding. According to Hepatitis Education Project Executive Director Michael Ninburg, the HCV community needs the resources to talk about the disease in an informed way. "HepCRedefined.com is designed to aggregate straightforward and accurate information in a single virtual destination," he explained.

Back to other news for November 2012

Excerpted from:
Drug Store News
11.09.2012; Alaric Dearment




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/69706/boehringer-ingelheim-launches-hepatitis-c-website.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.